NCT01888718View on ClinicalTrials.gov

Bioequivalence Study of Fexofenadine Hydrochloride Orally Disintegrated Tablets 30 mg Under Fasting Condition

PHASE1CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

February 28, 2011

Study Completion Date

March 31, 2011

Conditions
Healthy
Interventions
DRUG

Fexofenadine Hydrochloride

Fexofenadine Hydrochloride Orally Disintegrating Tablets 30 mg

Trial Locations (1)

500 037

Bioserve Clinical Research Private Limited, Bālānagar

Sponsors
All Listed Sponsors
lead

Dr. Reddy's Laboratories Limited

INDUSTRY